| Record ID | marc_loc_2016/BooksAll.2016.part25.utf8:106820291:1059 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part25.utf8:106820291:1059?format=raw |
LEADER: 01059cam a2200301 a 4500
001 96043029
003 DLC
005 20010611154934.0
008 960827s1997 nyua b 001 0 eng c
010 $a 96043029
020 $a1570594074 (alk. paper)
020 $a354061950X (International : alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC607.A26$bA545 1997
060 10 $aQV 185 A629 1996
082 00 $a616.97/92061$220
245 00 $aAnti-HIV nucleosides :$bpast, present, and future /$c[edited by] Hiroaki Mitsuya.
260 $aNew York :$bSpringer ;$aAustin :$bR.G. Landes,$cc1997.
300 $a178 p. ;$bill. ;$c26 cm.
490 1 $aMedical intelligence unit
504 $aIncludes bibliographical references and index.
650 0 $aNucleosides$xDerivatives$xTherapeutic use.
650 0 $aAIDS (Disease)$xChemotherapy.
650 12 $aNucleosides$xpharmacology.
650 22 $aAnti-Infective Agents$xpharmacology.
650 22 $aHIV$xdrug effects.
700 1 $aMitsuya, Hiroaki,$d1950-
830 0 $aMedical intelligence unit (Unnumbered)